Table 1.
Epidemiological data of the patients (P) and healthy controls (N) recruited in the study.
| Patient ID | Age (years) |
Sex | HEV IgM | HBsAg | HCV IgG | Bilirubin (mg/dl) |
SGOT (IU/ml) |
SGPT (IU/ml) |
|---|---|---|---|---|---|---|---|---|
| P1 | 58 | Male | + | - | - | 19.1 | 41 | 71 |
| P2 | 39 | Male | + | - | - | ND | ND | ND |
| P3 | 21 | Male | + | - | - | 2.9 | ND | ND |
| P4 | 14 | Male | + | - | - | 9.4 | 620 | 934 |
| P5 | 25 | Male | + | - | - | 9.5 | 280 | 476 |
| P6 | 24 | Male | + | - | - | 4.6 | 86 | 172 |
| P7 | 22 | Male | + | - | - | 9.8 | 106 | 192 |
| P8 | 26 | Male | + | - | - | 14 | 386 | 820 |
| P9 | 30 | Male | + | - | - | 8 | 292 | 640 |
| P10 | 22 | Male | + | - | - | 5.8 | 230 | 510 |
| P11 | 30 | Male | + | - | - | 9.6 | 193 | 334 |
| P12 | 35 | Male | + | - | - | 4.6 | 116 | 328 |
| P13 | 33 | Male | + | - | - | 6.4 | 195 | 393 |
| P14 | 24 | Male | + | - | - | 8.5 | 810 | 1040 |
| P15 | 39 | Male | + | - | - | 4.1 | 202 | 265 |
| P16 | 31 | Male | + | - | - | 9.1 | 356 | 470 |
| P17 | 24 | Male | + | - | - | 8.2 | 219 | 348 |
| P18 | 36 | Male | + | - | - | 17 | 1453 | 1503 |
| P19 | 34 | Male | + | - | - | 20.9 | 1008 | 1170 |
| P20 | 29 | Male | + | - | - | 12.8 | 1956 | 2696 |
| P21 | 23 | Male | + | - | - | 12.5 | 69 | 176 |
| P22 | 35 | Male | + | - | - | 5.2 | 464 | 1476 |
| P23 | 40 | Male | + | - | - | 10.4 | 159 | 340 |
| P24 | 36 | Male | + | - | - | 6.1 | 2309 | 4266 |
| P25 | 51 | Male | + | - | - | 24.3 | 61 | 104 |
| N1 | 45 | Male | - | - | - | ND | ND | ND |
| N2 | 30 | Male | - | - | - | ND | ND | ND |
| N3 | 33 | Male | - | - | - | ND | ND | ND |
| N4 | 31 | Male | - | - | - | ND | ND | ND |
| N5 | 27 | Male | - | - | - | ND | ND | ND |
| N6 | 31 | Male | - | - | - | ND | ND | ND |
| N7 | 27 | Male | - | - | - | ND | ND | ND |
| N8 | 28 | Male | - | - | - | ND | ND | ND |
| N9 | 31 | Male | - | - | - | ND | ND | ND |
| N10 | 28 | Male | - | - | - | ND | ND | ND |
ND: Not done